Developing vaccines to combat pandemic influenza

Developing vaccines to combat pandemic influenza

Item
http://www.wikidata.org/entity/Q30408108
The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.Influenza Virus-like Particle Containing Two Different Subtypes of Hemagglutinin Confers Protection in Mice Against Lethal Challenge With A/PR8 (H1N1) and A/HK (H3N2) Viruses.Development of an improved polykaryon-based influenza virus rescue system.Protease activation mutants elicit protective immunity against highly pathogenic avian influenza viruses of subtype H7 in chickens and mice.An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans.Many ways to make an influenza virus--review of influenza virus reverse genetics methods.The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process
P2860

Developing vaccines to combat pandemic influenza

Item
http://www.wikidata.org/entity/Q30408108
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Developing vaccines to combat pandemic influenza
@ast
Developing vaccines to combat pandemic influenza
@en
type
label
Developing vaccines to combat pandemic influenza
@ast
Developing vaccines to combat pandemic influenza
@en
prefLabel
Developing vaccines to combat pandemic influenza
@ast
Developing vaccines to combat pandemic influenza
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Developing vaccines to combat pandemic influenza
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932